Published on 21 February 2012
A patient-centred paradigm for the biosimilars market
Author(s): James N Class, PhD, Lauren Langis, JD
biosimilars, medical devices, outcomes, patients, prescribers, public policy
DOI: 10.5639/gabij.2012.0101.006
41.557 views